# Using Mirabegron to Increase BP in Patients With POTS

> **NCT06133075** · PHASE2 · COMPLETED · sponsor: **Cedars-Sinai Medical Center** · enrollment: 20 (actual)

## Conditions studied

- Postural Orthostatic Tachycardia Syndrome
- Chronic Orthostatic Intolerance
- Syncope

## Interventions

- **DRUG:** Mirabegron 50 MG
- **DRUG:** Mirabegron 25 MG

## Key facts

- **NCT ID:** NCT06133075
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-22
- **Primary completion:** 2025-05-20
- **Final completion:** 2025-07-25
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06133075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06133075, "Using Mirabegron to Increase BP in Patients With POTS". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06133075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*